Yuyu Pharma introduces enhanced ERP system

SEOUL, South Korea, March 31, 2020 /PRNewswire/ — Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP) system to identify real-time management conditions and enhance system management for more efficient decision-making.

The new ERP system took more than 1 year to develop. The focus was integrating the ERP systems of not only Yuyu Pharma, but with those of Yuyu’s affiliates such as Yuyu Teijin Medicare.

The new ERP system integrates the information from Sales, Manufacturing, Purchasing, Quality Control, Finance, and Human Resources into real-time links, allowing a more effective cost, profit analysis. Details of each activity, such as clinical trials, post-marketing surveys, and academic symposiums are subdivided, and the expenses incurred by each activity are automatically reconciled with details of use of funds. This makes it easier to manage and report item by classifications.

“The ERP system allows for more insightful and secure methods for data management. We will be able to look at how we are managing the entire company process and leverage that to make better decisions. We will continue to upgrade our system to be competitive in today’s environment,” said CEO Robert Yu.

About Yuyu Pharma

Yuyu Pharma(KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/yuyu-pharma-introduces-enhanced-erp-system-301031718.html

SOURCE Yuyu Pharma

Staff

Recent Posts

CardioComm Solutions Provides Update Respecting Debt Settlement

Toronto, Ontario--(Newsfile Corp. - July 8, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or…

5 mins ago

CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the…

59 mins ago

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on…

60 mins ago

Youth Inventors Compete at The Henry Ford during RTX Invention Convention U.S. Nationals June 5-7, 2024, in Dearborn, Michigan

DEARBORN, Mich., July 8, 2024 /PRNewswire/ -- The Henry Ford hosted over 435 youth inventors…

1 hour ago

Leading Medical Claims Management provider, Medlogix, LLC Announces the Acquisition of ReviewWorks

HAMILTON, N.J., July 8, 2024 /PRNewswire/ -- Medlogix, LLC, a leading, national medical claims management…

1 hour ago

Gymdesk Announces a $32.5 Million Strategic Growth Investment from Five Elms Capital

KANSAS CITY, Mo., July 8, 2024 /PRNewswire/ -- Gymdesk, a leading provider of member management…

1 hour ago